Xenetic Biosciences Inc
NASDAQ:XBIO 11:59:44 AM EDT
Market Cap (Intraday) | 5.16M |
Current PE | N/A |
Forward PE | N/A |
2yr Forward PE | N/A |
10-Day MA | $3.16 |
50-Day MA | $3.80 |
200-Day MA | $3.96 |
Xenetic Biosciences Inc Stock, NASDAQ:XBIO
945 Concord Street, Suite 102, Framingham, Massachusetts 01701
United States of America
Phone: +1.781.778.7720
Number of Employees: 4
Description
Xenetic Biosciences, Inc. is a biopharmaceutical company engaged in the advancement of cell-based therapeutics to target the B-cell receptor on the surface of an individual patient�s malignant tumor cells. Its product pipeline includes XCart Platform and Polyxen. The company was founded on August 9, 2011 and is headquartered in Framingham, MA.